ReviewJornal brasileiro de nefrologia

SGLT2 inhibitors and NLRP3 inflammasome: potential target in diabetic kidney disease.

Paulo André Bispo Machado Júnior et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.